The cash-saving measures come after interim analysis showed the company’s lead cancer drug only showed modest improvement in ...

Triveni Bio has secured $115m in a Series B funding round to advance its preclinical antibody candidates for immunological ...

Focus is turning to the development of peptide analogs of antibody-derived radiotherapeutics, according to Dr. Dave Madge.

Exscientia detailed how its robotics lab in Oxfordshire, UK is increasing productivity and efficiency in developing new ...

The funds will support the development of LoQus23’s lead candidate, its MutSβ inhibitor, as it enters clinical development.

GlobalData’s report assesses the drugs in the Protein Kinase C Theta Type pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.

GlobalData’s report assesses the drugs in the Serine Protein Kinase ATM pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.

GlobalData’s report assesses the drugs in the Retinoic Acid Receptor Gamma pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.

GlobalData’s report assesses the drugs in the Histone Deacetylase 6 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.

GlobalData’s report assesses the drugs in the Toll Like Receptor 4 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.

GlobalData’s report assesses the drugs in the Transthyretin pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.

GlobalData’s report assesses the drugs in the Alpha Synuclein pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.